Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06277271
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2024-01-19
Brief Title:
E-cigarettes as a Harm Reduction Strategy
Sponsor:
Prisma Health-Upstate
Organization:
Prisma Health-Upstate
Study Overview
Official Title:
E-cigarettes for Harm Reduction in Adults With Opioid Use Disorder
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
E-cigarettes have emerged as an effective strategy for replacing cigarettes among smokers from the general population but there is a dearth of studies investigating their utility in replacing cigarettes among smokers with opioid use disorder OUD This study aims to evaluate the feasibility and acceptability of implementing a cigarette harm reduction intervention involving e-cigarettes in office-based buprenorphine clinics
Detailed Description:
Between 84-94 of individuals with opioid use disorder OUD smoke cigarettes a rate six times higher than the general US adult population Despite the majority of smokers with OUD expressing motivation to quit cessation rates remain extremely low even with evidence-based medications E-cigarettes have emerged as a harm reduction strategy for smokers unable or unwilling to quit Research on the effectiveness of e-cigarettes for smoking reduction among individuals with OUD on buprenorphinemethadone maintenance treatment is scarce but promising This study is an open-label single-arm clinical trial testing the use of e-cigarettes as a harm reduction strategy among smokers with OUD on buprenorphine in a real-world setting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None